Task: Answer the multiple-choice question.
Question: Which drug exhibits a 3.167\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
(a) CCn1c(C)c(P(=O)(N2CCOCC2)N2CCOCC2)c2ccccc21
(b) O=C(CN1CCCCC1)Nc1ccc(NC(=O)c2ccc(Cl)cc2)cc1Cl
(c) COc1ccc(/C(C)=N/NS(=O)(=O)c2ccccc2)c(OC)c1
Answer: a. CCn1c(C)c(P(=O)(N2CCOCC2)N2CCOCC2)c2ccccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCn1c(C)c(P(=O)(N2CCOCC2)N2CCOCC2)c2ccccc21
CCn1c(C)c(P(=O)(N2CCOCC2)N2CCOCC2)c2ccccc21
4-[(1-ethyl-2-methylindol-3-yl)-morpholin-4-ylphosphoryl]morpholine